These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 16272170)

  • 1. Reduced expression of EphB2 that parallels invasion and metastasis in colorectal tumours.
    Guo DL; Zhang J; Yuen ST; Tsui WY; Chan AS; Ho C; Ji J; Leung SY; Chen X
    Carcinogenesis; 2006 Mar; 27(3):454-64. PubMed ID: 16272170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EphB2 is a prognostic factor in colorectal cancer.
    Jubb AM; Zhong F; Bheddah S; Grabsch HI; Frantz GD; Mueller W; Kavi V; Quirke P; Polakis P; Koeppen H
    Clin Cancer Res; 2005 Jul; 11(14):5181-7. PubMed ID: 16033834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EphB2 expression across 138 human tumor types in a tissue microarray: high levels of expression in gastrointestinal cancers.
    Lugli A; Spichtin H; Maurer R; Mirlacher M; Kiefer J; Huusko P; Azorsa D; Terracciano L; Sauter G; Kallioniemi OP; Mousses S; Tornillo L
    Clin Cancer Res; 2005 Sep; 11(18):6450-8. PubMed ID: 16166419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
    Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
    BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. c-Rel is a transcriptional repressor of EPHB2 in colorectal cancer.
    Fu T; Li P; Wang H; He Y; Luo D; Zhang A; Tong W; Zhang L; Liu B; Hu C
    J Pathol; 2009 Sep; 219(1):103-13. PubMed ID: 19621336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced p16 expression correlates with lymphatic invasion in colorectal cancers.
    Tada T; Watanabe T; Kazama S; Kanazawa T; Hata K; Komuro Y; Nagawa H
    Hepatogastroenterology; 2003; 50(54):1756-60. PubMed ID: 14696398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulation of the peripheral benzodiazepine receptor during human colorectal carcinogenesis and tumor spread.
    Maaser K; Grabowski P; Oezdem Y; Krahn A; Heine B; Stein H; Buhr H; Zeitz M; Scherübl H
    Clin Cancer Res; 2005 Mar; 11(5):1751-6. PubMed ID: 15755996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High expression of PRL-3 promotes cancer cell motility and liver metastasis in human colorectal cancer: a predictive molecular marker of metachronous liver and lung metastases.
    Kato H; Semba S; Miskad UA; Seo Y; Kasuga M; Yokozaki H
    Clin Cancer Res; 2004 Nov; 10(21):7318-28. PubMed ID: 15534108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of EphA4 gene and reduced expression of EphB2 gene correlates with liver metastasis in colorectal cancer.
    Oshima T; Akaike M; Yoshihara K; Shiozawa M; Yamamoto N; Sato T; Akihito N; Nagano Y; Fujii S; Kunisaki C; Wada N; Rino Y; Tanaka K; Masuda M; Imada T
    Int J Oncol; 2008 Sep; 33(3):573-7. PubMed ID: 18695888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preferential induction of EphB4 over EphB2 and its implication in colorectal cancer progression.
    Kumar SR; Scehnet JS; Ley EJ; Singh J; Krasnoperov V; Liu R; Manchanda PK; Ladner RD; Hawes D; Weaver FA; Beart RW; Singh G; Nguyen C; Kahn M; Gill PS
    Cancer Res; 2009 May; 69(9):3736-45. PubMed ID: 19366806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leptin expression correlates with favorable clinicopathologic phenotype and better prognosis in colorectal adenocarcinoma.
    Paik SS; Jang SM; Jang KS; Lee KH; Choi D; Jang SJ
    Ann Surg Oncol; 2009 Feb; 16(2):297-303. PubMed ID: 19050975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
    Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
    Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of KAI1 expression in the progression of colorectal cancer.
    Lombardi DP; Geradts J; Foley JF; Chiao C; Lamb PW; Barrett JC
    Cancer Res; 1999 Nov; 59(22):5724-31. PubMed ID: 10582691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential CXC receptor expression in colorectal carcinomas.
    Rubie C; Kollmar O; Frick VO; Wagner M; Brittner B; Gräber S; Schilling MK
    Scand J Immunol; 2008 Dec; 68(6):635-44. PubMed ID: 18959627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Raf kinase inhibitor protein expression in a survival analysis of colorectal cancer patients.
    Al-Mulla F; Hagan S; Behbehani AI; Bitar MS; George SS; Going JJ; García JJ; Scott L; Fyfe N; Murray GI; Kolch W
    J Clin Oncol; 2006 Dec; 24(36):5672-9. PubMed ID: 17179102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients.
    Ottaiano A; Franco R; Aiello Talamanca A; Liguori G; Tatangelo F; Delrio P; Nasti G; Barletta E; Facchini G; Daniele B; Di Blasi A; Napolitano M; Ieranò C; Calemma R; Leonardi E; Albino V; De Angelis V; Falanga M; Boccia V; Capuozzo M; Parisi V; Botti G; Castello G; Vincenzo Iaffaioli R; Scala S
    Clin Cancer Res; 2006 May; 12(9):2795-803. PubMed ID: 16675573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD44-positive colorectal adenoma cells express the potential stem cell markers musashi antigen (msi1) and ephrin B2 receptor (EphB2).
    Schulenburg A; Cech P; Herbacek I; Marian B; Wrba F; Valent P; Ulrich-Pur H
    J Pathol; 2007 Oct; 213(2):152-60. PubMed ID: 17708598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatty acid binding protein 6 is overexpressed in colorectal cancer.
    Ohmachi T; Inoue H; Mimori K; Tanaka F; Sasaki A; Kanda T; Fujii H; Yanaga K; Mori M
    Clin Cancer Res; 2006 Sep; 12(17):5090-5. PubMed ID: 16951225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EphB receptor activity suppresses colorectal cancer progression.
    Batlle E; Bacani J; Begthel H; Jonkheer S; Gregorieff A; van de Born M; Malats N; Sancho E; Boon E; Pawson T; Gallinger S; Pals S; Clevers H
    Nature; 2005 Jun; 435(7045):1126-30. PubMed ID: 15973414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression profiling of colorectal cancer and metastases divides tumours according to their clinicopathological stage.
    Koehler A; Bataille F; Schmid C; Ruemmele P; Waldeck A; Blaszyk H; Hartmann A; Hofstaedter F; Dietmaier W
    J Pathol; 2004 Sep; 204(1):65-74. PubMed ID: 15307139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.